glp-1 clinical studies The Trial Landscape in 2024 Clinical efficacy results from clinical

& Satija, B

Injectable and conductive nanomicelle hydrogel with -tocopherol encapsulation for enhanced myocardial infarction repair

Easy installation for hassle-free upgrades

Liquid and syrup formulations have more pathways for odor development because water and solvents can interact with the active ingredient or microbes

Inhalation is a convenient method for clinical use, with no abnormal odour and no significant side effects

Our comprehensive approach, spanning controlled release, targeted delivery, pulmonary, transdermal, oral, ocular, and hybrid systems, allows researchers and developers to address complex formulation challenges efficiently